Bo Zhang

13PUBLICATIONS
12CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Pacific Peoples theory of change models for healthGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 14, 2026
OGTT-Derived β-Cell Function-Based Stratification of 2-Year Glycaemic Transitions in Chinese Adults With Prediabetes.

|Aug 10, 2026
Early Weight Loss in Impaired Glucose Tolerance Is Associated With Reduced Long-term Mortality and Cardiovascular Risk: The Da Qing Diabetes Prevention Outcome Study.

|Dec 17, 2025
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes.

Lixin Guo, Bo Zhang, Xia Xue

|Oct 04, 2024
Assessing and predicting type 2 diabetes risk with triglyceride glucose-body mass index in the Chinese nondiabetic population-Data from long-term follow-up of Da Qing IGT and Diabetes Study.

Haixu Wang, Siyao He, Jinping Wang

|Aug 19, 2024
Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long-term risk of cardiovascular events and mortality.

Fei Chen, Yifan He, Jinping Wang

|Apr 07, 2024
Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24-week, randomized, double-blind, active-controlled, phase 3 trial.

Lingding Xie, Jie Han, Zhifeng Cheng

Pageof 3

Frequent Collaborators

6 joint publications

Guangwei Li

4 joint publications

Qiuhong Gong

4 joint publications

Xin Qian

3 joint publications

Fei Chen